# ABSORICA LD
> **NDA211913** · New Drug Application · Sponsor: SUN PHARM · Approved 2019-11-05
## Drug
- **FDA Application Number:** NDA211913
- **Application type:** New Drug Application
- **Brand name:** ABSORICA LD
- **Generic name:** ISOTRETINOIN
- **Active ingredients:** ISOTRETINOIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARM
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2019-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211913)
---
*MORVS · CC0 1.0*